Sintesi di nuovi derivati tri-componente per target photodynamic therapy della neoplasia prostatica

Ragno, Daniele (2012) Sintesi di nuovi derivati tri-componente per target photodynamic therapy della neoplasia prostatica. [Laurea magistrale], Università di Bologna, Corso di Studio in Chimica industriale [LM-DM270]
Documenti full-text disponibili:
Documento PDF
Download (2MB) | Anteprima


Therapies for the treatment of prostate cancer show several limitations, especially when the cancer metastasizes or acquires resistance to treatment. In addition, most of the therapies currently used entails the occurrence of serious side effects. A different therapeutic approach, more selective and less invasive with respect either to radio or to chemotherapy, is represented by the photodynamic therapy (PDT). The PDT is a treatment that makes use of photosensitive drugs: these agents are pharmacologically inactive until they are irradiated with light at an appropriate wavelength and in the presence of oxygen. The drug, activated by light, forms singlet oxygen, a highly reactive chemical species directly responsible for DNA damage, thus of cell death. In this thesis we present two synthetic strategies for the preparation of two new tri-component derivatives for photodynamic therapy of advanced prostate cancer, namely DRPDT1 and DRPDT2. Both derivatives are formed by three basic elements covalently bounded to each other: a specific ligand with high affinity for the androgen receptor, a suitably chosen spacer molecule and a photoactivated molecule. In particular, DRPDT2 differs from DRPDT1 from the nature of the AR ligand. In fact, in the case of DRPDT2 we used a synthetically engineered androgen receptor ligand able to photo-react even in the absence of oxygen, by delivering NO radical. The presence of this additional pharmacophore, together with the porphyrin, may ensure an additive/synergistic effect to the photo-stimulated therapy, which than may act both in the presence of oxygen and in hypoxic conditions. This approach represents the first example of multimodal photodynamic therapy for prostate cancer.

Tipologia del documento
Tesi di laurea (Laurea magistrale)
Autore della tesi
Ragno, Daniele
Relatore della tesi
Correlatore della tesi
Corso di studio
Ordinamento Cds
Parole chiave
cancro alla prostata, photodynamic therapy, sintesi organica, AR-antagonisti
Data di discussione della Tesi
Luglio 2012

Altri metadati

Statistica sui download

Gestione del documento: Visualizza il documento